Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Share-based Compensation (2020 - 2025)

Celularity (CELU) has disclosed Share-based Compensation for 6 consecutive years, with $471000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Share-based Compensation fell 82.37% to $471000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $3.7 million, a 69.44% decrease, with the full-year FY2024 number at $11.6 million, down 22.96% from a year prior.
  • Share-based Compensation was $471000.0 for Q3 2025 at Celularity, up from -$2.3 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $28.2 million in Q2 2021 to a low of -$32.7 million in Q4 2021.
  • A 5-year average of $2.6 million and a median of $3.0 million in 2024 define the central range for Share-based Compensation.
  • Peak YoY movement for Share-based Compensation: crashed 3322.83% in 2021, then soared 140.04% in 2022.
  • Celularity's Share-based Compensation stood at -$32.7 million in 2021, then skyrocketed by 113.39% to $4.4 million in 2022, then fell by 18.49% to $3.6 million in 2023, then decreased by 17.73% to $2.9 million in 2024, then crashed by 83.99% to $471000.0 in 2025.
  • Per Business Quant, the three most recent readings for CELU's Share-based Compensation are $471000.0 (Q3 2025), -$2.3 million (Q2 2025), and $2.6 million (Q1 2025).